What is Tesamorelin?
The short answer
Tesamorelin is a lab-made form of the hormone that tells the body to make growth hormone. In the US, you need a prescription to get Tesamorelin.
- 4 sources
- Status as of
- How we source
- Ellum doesn't sell peptides.
Get updates on Tesamorelin
What it is
- Type
- GHRH analog (peptide)
- Also known as
- tesa
- How it works
- Stimulates the pituitary to release growth hormone.
Regulatory status
FDA-approved (Rx) How we label status
As of October 4, 2026, Tesamorelin is an FDA-approved prescription drug for excess abdominal fat in HIV-associated lipodystrophy.
- Federal (FDA)
- Approved Rx (Egrifta BLA022505, 2010; current Egrifta WR)
- 503A compounding
- Approved-drug component (not in any 503A category) (as of May 14, 2026)
- WADA 2026
- S2.2.4
US enforcement actions
5 US enforcement actions since 2026.
Actions by US federal and state agencies whose documents name Tesamorelin. Each row links to the government's own document.
Scroll sideways to see all columns.
US enforcement actions table
| Date | Agency | Action | Document |
|---|---|---|---|
| FDA | Warning letter | FDA document, warning letter, August 24, 2026, 1 of 5 that day, on fda.gov | |
| FDA | Warning letter | FDA document, warning letter, August 24, 2026, 2 of 5 that day, on fda.gov | |
| FDA | Warning letter | FDA document, warning letter, August 24, 2026, 3 of 5 that day, on fda.gov | |
| FDA | Warning letter | FDA document, warning letter, August 24, 2026, 4 of 5 that day, on fda.gov | |
| FDA | Warning letter | FDA document, warning letter, August 24, 2026, 5 of 5 that day, on fda.gov |
Forms and brands
Scroll sideways to see all columns.
Forms and brands table
| Name | Kind | Status | FDA status | As of |
|---|---|---|---|---|
| Egrifta | Brand | FDA-approved (Rx) | Approved Rx (BLA022505, 2010; current Egrifta WR and SV; HIV lipodystrophy abdominal fat) |
References
Sources as of October 4, 2026